Source map — US FDA declines to approve Summit lung cancer drug after trial misses key survival goal
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| Fierce Pharma | news | 60% |
| Reuters | news | 60% |
| Yahoo Finance | news | 60% |
| Bloomberg.com | news | 60% |
| Endpoints News | news | 60% |
| Financial Times | news | 60% |
| The New York Times | news | 60% |
| Business Wire | news | 60% |
| consent.yahoo.com | news | 50% |
| www.marketscreener.com | news | 50% |
| digg.com | news | 50% |
| ca.marketscreener.com | news | 50% |
| arynews.tv | news | 50% |
| malaysia.news.yahoo.com | news | 50% |